Boceprevir versus placebo with pegylated interferon alfa-2b and ribavirin for treatment of hepatitis C virus genotype 1 in patients with HIV: a randomised, double-blind, controlled phase 2 trial

Sulkowski, Mark, Prof ; Pol, Stanislas, Prof ; Mallolas, Josep, MD ; Fainboim, Hugo, MD ; Cooper, Curtis, MD ; Slim, Jihad, MD ; Rivero, Antonio, MD ; Mak, Carmen, PhD ; Thompson, Seth, PhD ; Howe, Anita YM, PhD ; Wenning, Larissa, PhD ; Sklar, Peter, MD ; Wahl, Janice, MD ; Greaves, Wayne, Dr

The Lancet infectious diseases, 2013-07, Vol.13 (7), p.597-605 [Periódico revisado por pares]

London: Elsevier Ltd

Texto completo disponível